KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Incyte (INCY) Return on Sales (2016 - 2025)

Historic Return on Sales for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to 0.31%.

  • Incyte's Return on Sales rose 2200.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.01% for FY2024, which is 1500.0% down from last year.
  • Per Incyte's latest filing, its Return on Sales stood at 0.31% for Q3 2025, which was up 2200.0% from 0.33% recorded in Q2 2025.
  • In the past 5 years, Incyte's Return on Sales ranged from a high of 0.65% in Q4 2021 and a low of 0.43% during Q2 2024
  • For the 5-year period, Incyte's Return on Sales averaged around 0.16%, with its median value being 0.18% (2022).
  • In the last 5 years, Incyte's Return on Sales skyrocketed by 13600bps in 2021 and then tumbled by -6400bps in 2024.
  • Incyte's Return on Sales (Quarter) stood at 0.65% in 2021, then plummeted by -95bps to 0.03% in 2022, then surged by 546bps to 0.2% in 2023, then dropped by -14bps to 0.17% in 2024, then soared by 82bps to 0.31% in 2025.
  • Its Return on Sales was 0.31% in Q3 2025, compared to 0.33% in Q2 2025 and 0.15% in Q1 2025.